Arne von Bonin
Nessuna posizione attualmente
Profilo
Arne von Bonin worked as a Research Director at Bayer Pharma AG from 2008 to 2008, and as a Scientist at Novartis AG.
He also worked as a Principal at Karolinska Institutet and Bernhard-Nocht-Institut für Tropenmedizin from 2001 to 1994 and 2001 to 2001, respectively.
Additionally, he served as the Chief Technology Officer at AFFiRiS AG in 2015.
Dr. von Bonin earned a doctorate degree from Max-Planck-Institute for Molecular Genetics in 1993.
Precedenti posizioni note di Arne von Bonin
Società | Posizione | Fine |
---|---|---|
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Direttore Tecnico/Scientifico/R&S | 01/01/2008 |
Bernhard-Nocht-Institut für Tropenmedizin
Bernhard-Nocht-Institut für Tropenmedizin Hospital/Nursing ManagementHealth Services The Bernhard-Nocht-Institut für Tropenmedizin is a research institute based in Hamburg, Germany. The institute focuses on tropical medicine and aims to minimize the risk of dangerous pathogens and toxins for everyone. The German company works with partner institutions in various countries to train laboratory staff and conduct research on diseases, diagnostics, and capacity strengthening. The institute also offers training courses, laboratory diagnostics, and information on travel and clinical research. | Corporate Officer/Principal | 01/01/2001 |
Karolinska Institutet | Corporate Officer/Principal | - |
NOVARTIS AG | Direttore Tecnico/Scientifico/R&S | - |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Arne von Bonin
Max-Planck-Institute for Molecular Genetics | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NOVARTIS AG | Health Technology |
Aziende private | 3 |
---|---|
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Health Services |
Bernhard-Nocht-Institut für Tropenmedizin
Bernhard-Nocht-Institut für Tropenmedizin Hospital/Nursing ManagementHealth Services The Bernhard-Nocht-Institut für Tropenmedizin is a research institute based in Hamburg, Germany. The institute focuses on tropical medicine and aims to minimize the risk of dangerous pathogens and toxins for everyone. The German company works with partner institutions in various countries to train laboratory staff and conduct research on diseases, diagnostics, and capacity strengthening. The institute also offers training courses, laboratory diagnostics, and information on travel and clinical research. | Health Services |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
- Borsa valori
- Insiders
- Arne von Bonin